Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
BioConferenceLive

Enhanced and Upgraded Particle Size and Shape Analyzer Now Available

By BiotechDaily International staff writers
Posted on 02 Jun 2014
Image: The CAMSIZER P4 particle size and shape analyzer (Photo courtesy of Retsch Technology).
Image: The CAMSIZER P4 particle size and shape analyzer (Photo courtesy of Retsch Technology).
An upgraded and enhanced version of a well-proven system for the determination of particle size and shape has recently become available.

The new Retsch Technology (Haan, Germany) CAMSIZER P4 is the systematically enhanced and optimized version of the well-proven CAMSIZER system.

The CAMSIZER P4 operates on the principle of digital image analysis. The sample is transported to the measurement field via a vibratory feeder where the particles drop between a planar light source and two CCD cameras. The projected particle shadows are recorded at a rate of more than 60 images per second and analyzed. In this way almost every single particle in the bulk material flow is recorded and evaluated. It is therefore possible to measure a wide range of particles from 20 micrometers to 30 millimeters with extreme accuracy and without the necessity of switching measuring ranges or making adjustments.

Due to its extremely short exposure times, the LED strobe light source generates sharp and distortion-free images. The sharp contrast allows, at the same time, details of the surface structure of the particles may be seen with almost microscope-like clarity. The frequency of the light flashes is so high that the flashes are not visible to the naked eye.

The CAMSIZER P4's zoom camera provides maximum resolution down to the fine range, while the basic camera records larger particles and guarantees results with high statistical certainty. This ensures excellent reproducibility of the CAMSIZER measuring results, even if only a relatively small sample amount is available.

Complementing its software upgrades, the CAMSIZER P4's new software package offers additional evaluation possibilities, such as separate storage of all particle images in a data base or three-dimensional display of measurement results as scatter plots.

Related Links:

Retsch Technology




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Blocking the activity of HSP101 may imprison the malaria parasite inside its protective vacuole within the red blood cell. In the electron micrograph, the malaria parasites appear in blue and uninfected red blood cells are shown in red (Photo courtesy of the [US] National Institute of Allergy and Infectious Diseases).

Heat Shock Protein Plays Critical Role in Malaria Parasite Protein Trafficking

A pair of recent papers described the molecular operators that enable the malaria parasite Plasmodium falciparum to export a large variety of proteins across the parasitophorous vacuolar membrane (PVM)... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.